{"meta":{"query_hash":"f4471e250e4d","filters":{"venue":"Asian Pacific Journal of Allergy and Immunology"},"cohort_total":4,"direct_labels_cover":0,"predictions_cover":4,"exported":4,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f4471e250e4d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Asian+Pacific+Journal+of+Allergy+and+Immunology"},"results":[{"id":"W3000994790","doi":"10.12932/ap-290318-0290","title":"Polymorphisms in the interleukin 4 receptor and interleukin 13 genes in immediate allergic reactions to beta-lactam antibiotics: A case-control study","year":2018,"lang":"en","type":"article","venue":"Asian Pacific Journal of Allergy and Immunology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Single-nucleotide polymorphism; Haplotype; Allergy; Immunology; Population; Allele; Genetics; Chemistry; Genotype; Gene; Biology; Medicine","score_opus":0.01314576815688083,"score_gpt":0.2604465964084286,"score_spread":0.24730082825154776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000994790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988212,0.00044111043,0.00028229345,0.000028310236,0.000008470237,0.000023979088,0.00010460887,0.0000061026108,0.00028403036],"genre_scores_gemma":[0.9992544,0.00014976639,0.00019223656,0.000025806099,0.000017384633,0.000021548813,0.00013033714,0.0000031697562,0.00020540648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901974,0.00025115872,0.000081351805,0.00038109848,0.00016424083,0.00010241707],"domain_scores_gemma":[0.9988159,0.00039355864,0.0003434888,0.00019061904,0.00011521916,0.00014120259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009317633,0.0007110656,0.00055744103,0.001171351,0.00074450136,0.00061827956,0.00067033584,0.0008488893,0.0029506458],"category_scores_gemma":[0.0021528178,0.0006631868,0.00060284464,0.001065332,0.00050641387,0.0002976257,0.00037287988,0.00061009644,0.00024813475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008589141,0.00029091683,0.9906579,0.000032909826,0.00034126278,0.0030002617,0.00031331865,0.00006066445,0.0016406035,0.00010211488,0.00021547737,0.002485637],"study_design_scores_gemma":[0.00011626307,0.00041953815,0.99047476,0.000019411635,0.00030162215,0.0073420736,0.00017150676,0.00034352863,0.00027610804,0.000066743,0.00045702525,0.000011239887],"about_ca_topic_score_codex":0.004508988,"about_ca_topic_score_gemma":0.002404981,"teacher_disagreement_score":0.004508988,"about_ca_system_score_codex":0.0003852645,"about_ca_system_score_gemma":0.00026465158,"threshold_uncertainty_score":0.009870887},"labels":[],"label_agreement":null},{"id":"W3036531838","doi":"10.12932/ap-020220-0752","title":"Review of monoclonal antibody therapies in asthma and allergic diseases - a new paradigm for precision medicine","year":2020,"lang":"en","type":"review","venue":"Asian Pacific Journal of Allergy and Immunology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"Sanofi; AstraZeneca","keywords":"Medicine; Exhaled nitric oxide; Asthma; Immunology; Allergy; Immunoglobulin E; Allergic inflammation; Eosinophil; Omalizumab; Endotype; Precision medicine; Atopic dermatitis; Antibody; Pathology","score_opus":0.023003374574041714,"score_gpt":0.32941870895462555,"score_spread":0.3064153343805838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036531838","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004299754,0.9983968,0.00008673203,0.00065416034,0.00038586004,0.0000054491193,0.000014768923,0.0000044777175,0.00040870832],"genre_scores_gemma":[0.00041049338,0.99757046,0.00023356707,0.0009810508,0.00057755347,0.0000118403805,0.000024608118,0.0000014640276,0.00018894592],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9988404,0.00034713454,0.00027170018,0.0001187345,0.00035821798,0.000063871776],"domain_scores_gemma":[0.99671113,0.0022419742,0.0003468084,0.00007956421,0.0005117505,0.00010879889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002170491,0.0008821919,0.0026803773,0.0042514466,0.00039119206,0.0017514277,0.0014561136,0.0020726614,0.003902222],"category_scores_gemma":[0.0037976888,0.0003897922,0.0013611867,0.0041652056,0.000718935,0.0020269484,0.00076085655,0.0023106488,0.0011649289],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017114067,0.0000682781,0.00024906828,0.0780613,0.00043493905,0.0003649683,0.00014317513,0.0005225856,0.0011405353,0.0070443004,0.09325029,0.8185494],"study_design_scores_gemma":[0.000037688358,0.00014491334,0.00090993335,0.03343583,0.00044149757,0.001201745,0.00008511123,0.00011171602,0.00020481517,0.0033068089,0.9600979,0.00002202422],"about_ca_topic_score_codex":0.0015902134,"about_ca_topic_score_gemma":0.0027219998,"teacher_disagreement_score":0.0042514466,"about_ca_system_score_codex":0.0016397046,"about_ca_system_score_gemma":0.0028955154,"threshold_uncertainty_score":0.013054252},"labels":[],"label_agreement":null},{"id":"W3211128619","doi":"10.12932/ap-040121-1031","title":"Severe allergic asthma: Does alexithymia interfere with omalizumab treatment outcome?","year":2021,"lang":"en","type":"article","venue":"Asian Pacific Journal of Allergy and Immunology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Omalizumab; Medicine; Asthma; Immunoglobulin E; Quality of life (healthcare); Internal medicine; Toronto Alexithymia Scale; Gastroenterology; Physical therapy; Clinical psychology; Immunology; Antibody","score_opus":0.00929040873311349,"score_gpt":0.24195208642045163,"score_spread":0.23266167768733814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211128619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828124,0.00076188525,0.00004612992,0.00012853852,0.000014459027,0.000013896573,0.00006757542,0.0000021778296,0.0006842351],"genre_scores_gemma":[0.99960047,0.00014328312,0.000028372506,0.00002942799,0.000023465844,0.0000059738654,0.00009509361,6.6540565e-7,0.00007325517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995808,0.00014767026,0.00005077308,0.000062858926,0.000080731865,0.00007711596],"domain_scores_gemma":[0.9988458,0.00029535548,0.00055253133,0.000034416425,0.000063366126,0.00020850851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067894877,0.00017617611,0.00040704873,0.00021531044,0.00025938914,0.0004090027,0.00015651186,0.0003211045,0.0015920382],"category_scores_gemma":[0.0016475196,0.00007411185,0.00051048124,0.00028629263,0.000230374,0.00020884845,0.00023840596,0.00035905396,0.00017570586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003237297,0.00034768973,0.97709596,0.00006790268,0.0002178193,0.0002757925,0.00010573794,0.000091119735,0.0011693073,0.000035737386,0.00021386395,0.017141797],"study_design_scores_gemma":[0.000036143876,0.0009924299,0.99811125,0.00001219489,0.000066006985,0.0003106722,0.00005904427,0.00013805903,0.00007317073,0.000027085182,0.00017109483,0.000002989552],"about_ca_topic_score_codex":0.00047687168,"about_ca_topic_score_gemma":0.0008096452,"teacher_disagreement_score":0.0015920382,"about_ca_system_score_codex":0.00024287435,"about_ca_system_score_gemma":0.00023810407,"threshold_uncertainty_score":0.0053259134},"labels":[],"label_agreement":null},{"id":"W4200021190","doi":"10.12932/ap-240721-1196","title":"Nivolumab-induced diffuse type 2 rhinosinusitis: A case report","year":2022,"lang":"en","type":"article","venue":"Asian Pacific Journal of Allergy and Immunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Nivolumab; Medicine; Anosmia; Nasal congestion; Histopathology; Dermatology; Internal medicine; Gastroenterology; Surgery; Pathology; Nose; Cancer; Immunotherapy; Disease; Coronavirus disease 2019 (COVID-19)","score_opus":0.012941562513226883,"score_gpt":0.24942553924603725,"score_spread":0.23648397673281035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200021190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9492496,0.02369124,0.005726692,0.0048364904,0.0011693346,0.00035601758,0.000414458,0.0003655532,0.014190516],"genre_scores_gemma":[0.9910336,0.003531218,0.0013447581,0.0010666066,0.001355804,0.000042331983,0.0001234559,0.000027786362,0.0014743813],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99885464,0.000111760186,0.000117328695,0.00034396714,0.00015359539,0.00041874696],"domain_scores_gemma":[0.9988613,0.00024141604,0.00024077985,0.00014044189,0.000082771934,0.00043333755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050284114,0.0028787025,0.0018765024,0.0024536243,0.003106156,0.0023263677,0.0013955482,0.0072660204,0.002339025],"category_scores_gemma":[0.0018805616,0.0016175468,0.0020237532,0.0016699218,0.0018843926,0.0026177894,0.0019610978,0.004638505,0.0010638017],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015460031,0.000025445712,0.0022612952,0.000027973256,0.000010007749,0.9963588,0.00006987431,0.00003084824,0.0003616347,0.00006857813,0.00016375621,0.0006062162],"study_design_scores_gemma":[0.000009268693,0.000027175127,0.0015006536,0.000011064435,0.000009489389,0.9978042,0.00008211259,0.000102691745,0.000109787135,0.00005505659,0.00028173559,0.0000067618375],"about_ca_topic_score_codex":0.002261934,"about_ca_topic_score_gemma":0.003178583,"teacher_disagreement_score":0.0072660204,"about_ca_system_score_codex":0.001743139,"about_ca_system_score_gemma":0.0011040837,"threshold_uncertainty_score":0.01264739},"labels":[],"label_agreement":null}]}